Resistance Training Adaptations and Caffeine Intake

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-30
SponsorIstanbul University - Cerrahpasa

About this trial

This randomized, double-blind, placebo-controlled crossover trial investigates the effects of three different caffeine supplementation strategies on resistance training-induced adaptations in 180 caffeine-naive, inactive young adult males. Participants will undergo two 4-week supervised resistance training programs separated by a 2-week washout/crossover period. The three caffeine strategies are: (1) constant daily low-moderate dosing (3 mg/kg/day), (2) gradually escalating dose (3 to 6 mg/kg across weeks), and (3) training-day-only caffeine (3 mg/kg/day). Primary outcomes include non-invasive measures of integrated anabolism and hypertrophy (D2O-derived plasma proteomic fractional synthesis rate, DXA muscle volume) and strength metrics. Secondary outcomes include hormonal responses (insulin, cortisol, testosterone, IGF-1), sleep/recovery parameters, and adverse effects.

Eligibility criteria

Qualifiers

Male sex and age between 18-30 years

No history of caffeine use or very low habitual intake (<50 mg/day)

No participation in a regular resistance training program in the past 6 months

Body mass index (BMI) between 18.5-30 kg/m2

Disqualifiers

Presence of cardiovascular, metabolic, renal, hepatic, or other serious chronic diseases

Diagnosed psychiatric disorders or severe caffeine intolerance/allergy

Use of medications affecting caffeine metabolism or muscle anabolism (e.g., beta-blockers, antidepressants, anabolic steroids)

Musculoskeletal injuries that prevent safe resistance training

Trial design

Treatments tested in this trial

  • Caffeine (Constant Daily Dose)
  • Placebo (Constant Daily Dose)
  • Caffeine (Escalating Dose)
  • Placebo (Escalating Dose)
  • Caffeine (Training Days Only)
  • Placebo (Training Days Only)

Treatment groups

180 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Sponsors and collaborators

Istanbul University - Cerrahpasa

Lead sponsor

İstanbul Yeni Yüzyıl Üniversitesi

Collaborator